Produktname:(3S)-3-(5-amino-2-methyl-4-oxo-3,4-dihydroquinazolin-3-yl)(3-²H)piperidine-2,6-dione
IUPAC Name:(3S)-3-(5-amino-2-methyl-4-oxo-3,4-dihydroquinazolin-3-yl)(3-²H)piperidine-2,6-dione
- CAS:1620055-10-8
- Molekulare Formel:C14H14N4O3
- Reinheit:95%+
- Katalognummer:CM1045885
- Molekulargewicht:287.3
Packungseinheit |
Verfügbarer Vorrat |
Preis($) |
Menge |
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:1620055-10-8
- Molekulare Formel:C14H14N4O3
- Schmelzpunkt:-
- SMILES-Code:[2H][C@@]1(CCC(=O)NC1=O)N1C(C)=NC2=C(C(N)=CC=C2)C1=O
- Dichte:
- Katalognummer:CM1045885
- Molekulargewicht:287.3
- Siedepunkt:
- Mdl-Nr.:
- Lagerung:
Category Infos
- PROTAC-E3 Ligase Ligands
- Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.
- PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
- Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
- PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.